1. Evaluation of cis-diamminedichloroplatinum(II) combined with metoclopramide or sodium thiosulfate on L1210 leukemia in vitro and in vivo

   • Joseph J. Catino
   • Donna M. Francher
   • John E. Schurig

   Original Articles Pages: 1 - 4

2. Noninvasive fluorine-19 NMR study of fluoropyrimidine metabolism in cell cultures of human pancreatic and colon adenocarcinoma

   • Marie-C. Malet-Martino
   • Françoise Faure
   • Robert Martino

   Original Articles Pages: 5 - 10

3. A cellular analysis of long-term haematopoietic damage in mice after repeated treatment with cyclophosphamide

   • Graham Molineux
   • Chengxiong Xu
   • Nydia Garcia Testa

   Original Articles Pages: 11 - 16

4. Calcium antagonism by the antioestrogen tamoxifen

   • A. Lipton
   • I. D. Morris

   Original Articles Pages: 17 - 20

5. The antiproliferative properties of tamoxifen and phenothiazines may be mediated by a unique histamine receptor (?H₃) distinct from the calmodulin-binding site

   • Lorne J. Brandes
   • R. Patricia Bogdanovic
   • Ratna Bose

   Original Articles Pages: 21 - 23

6. Etoposide in prostatic cancer: experimental studies and phase II trial in patients with bidimensionally measurable disease

   • Howard I. Scher
   • Cora Sternberg
   • the Community Cancer Oncology Program Investigators

   Original Articles Pages: 24 - 26

7. Pharmacokinetics of mitoxantrone in humans following single-agent infusion or intra-arterial injection therapy or combined-agent infusion therapy

   • S. J. P. Van Belle
   • M. M. de Planque
   • J. G. McVie

   Original Articles Pages: 27 - 32

8. Phase I clinical and pharmacokinetic study of cyclophosphamide administered by five-day continuous intravenous infusion

   • N. Simon Tchekmedyian
   • Merrill J. Egorin
   • Joseph Aisner

   Original Articles Pages: 33 - 38

9. Pharmacokinetic and endocrinological parameters of a slow-release depot preparation of the GnRH analogue ICI 118630 (Zoladex) compared with a subcutaneous bolus and continuous subcutaneous infusion of the same drug in patients with prostatic cancer

   • Timothy J. Perren
   • Richard N. Clayton
   • Clive H. Young

   Original Articles Pages: 39 - 43

10. A phase I study of vinblastine tryptophan ester

    • F. Ceulemans
    • Y. Humblet
    • A. Trouet

    Original Articles Pages: 44 - 46

11. Biliary excretion and pharmacokinetics of 4'epidoxorubicin (epirubicin) in advanced cancer patients

    • Carlo M. Camaggi
    • Elena Strocchi
    • Franco Pannuti

    Original Articles Pages: 47 - 50

12. EVA treatment for recurrent or unresponsive Hodgkin's disease

    • M. A. Richards
    • J. H. Waxman
    • T. A. Lister

    Original Articles Pages: 51 - 53

13. A phase II study of human rDNA alpha-2 interferon in patients with low grade non-Hodgkin's lymphoma

    • J. Wagstaff
    • P. Loynds
    • D. Crowther

    Original Articles Pages: 54 - 58

14. Treatment of acute leukaemia with m-AMSA in combination with cytosine arabinoside

    • H. S. Dhaliwal
    • M. S. Shannon
    • T. A. Lister

    Original Articles Pages: 59 - 62

15. A toxicity study of recombinant interferon-gamma given by intravenous infusion to patients with advanced cancer

    • Kumar Sriskandan
    • Philip Garner
    • Dudley E. H. Tee

    Original Articles Pages: 63 - 68

16. Cumulative renal tubular damage associated with cisplatin nephrotoxicity

    • Marshall P. Goren
    • Reba K. Wright
    • Marc E. Horowitz

    Original Articles Pages: 69 - 73

17. High-dose cis-platinum combination chemotherapy in advanced nonseminomatous malignant germ cell tumours with emphasis on nephrotoxicity

    • Kirsten Sundby Hall
    • Sophie Dorothea Fosså
    • Magne Aas

    Original Articles Pages: 74 - 77

18. Cellular and plasma pharmacokinetics of weekly 20-mg 4′-epi-adriamycin bolus injection in patients with advanced breast carcinoma

    • P. A. J. Speth
    • P. C. M. Linssen
    • C. Haanen

    Original Articles Pages: 78 - 82

19. Decreased autolysis of dead cells in Adriamycin-resistant lines of the sarcoma 180 of mouse

    • J. Šonka
    • A. Günther
    • M. Volm

    Short Communication Pages: 83 - 85

20. Anti-emetic efficacy of dexamtheasone in combination for out-patients receiving cytotoxic chemotherapy

    • Simon G. Allan
    • Donald F. Farquhar
    • Robert C. F. Leonard

    Short Communication Pages: 86 - 87

21. A phase II antiemetic combination (COMD) for cisplatin-induced nausea and vomiting

    • Fausto Roila
    • Carlo Basurto
    • Maurizio Tonato

    Short Communication Pages: 88 - 89

22. The effect of food on the oral administration of 6-mercaptopurine

    • Neil K. Burton
    • Michael J. Barnett
    • T. Andrew Lister

    Short Communication Pages: 90 - 91

23. Cisplatin induces modulation of transferrin receptor during cellular differentiation in vitro

    • G. P. Tonini
    • M. T. Parodi
    • P. Cornaglia-Ferraris

    Letter to the Editors Pages: 92 - 92

24. Scholarship announcement

    Announcement Pages: 93 - 94